Fig. 3From: Integrating network pharmacology and animal experimental validation to investigate the action mechanism of oleanolic acid in obesityMolecular docking models of OA with possible core anti-obesity targets. A PPARG, B PPARA, C MAPK3, D NR3C1, E PTGS2, F CYP19A1, G CNR1, H HSD11B1, and I AGTR1Back to article page